| |
| |
|
| Insider
Information: |
Adams Brian |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
451,836 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,163,093 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
451,836 |
|
|
| Total
Value |
$2,163,093 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
22
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
1
|
21
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -23.6%
|
-707.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Keryx Biopharmaceuticals Inc |
KERX |
General Counsel and Se... |
2018-02-15 |
126,069 |
|
0 |
Premium* |
|
|
Relay Therapeutics, Inc. |
RLAY |
|
2024-04-29 |
325,767 |
2020-07-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KERX |
Keryx Biopharmaceuticals ... |
General CounselOfficer |
• – – |
2015-03-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
63,875 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
• – – |
2015-04-15 |
4 |
S |
$12.40 |
$53,568 |
D/D |
(4,320) |
59,555 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
• – – |
2015-07-15 |
4 |
S |
$9.99 |
$10,849 |
D/D |
(1,086) |
58,469 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
• – – |
2015-10-15 |
4 |
S |
$4.01 |
$4,054 |
D/D |
(1,011) |
57,458 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
• – – |
2016-01-05 |
4/A |
S |
$4.83 |
$14,504 |
D/D |
(3,003) |
54,455 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
• – – |
2016-01-06 |
4 |
S |
$5.16 |
$15,501 |
D/D |
(3,004) |
54,454 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
• – – |
2016-01-06 |
4/A |
S |
$4.70 |
$5 |
D/D |
(1) |
54,454 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
• – – |
2016-01-15 |
4 |
S |
$3.30 |
$4,363 |
D/D |
(1,322) |
53,132 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
• – – |
2016-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
53,750 |
106,882 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
• – – |
2016-04-05 |
4 |
S |
$4.50 |
$3,416 |
D/D |
(759) |
106,123 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
• – – |
2016-04-15 |
4 |
S |
$5.05 |
$5,353 |
D/D |
(1,060) |
105,063 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
• – – |
2016-07-05 |
4 |
S |
$6.66 |
$4,396 |
D/D |
(660) |
104,403 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
• – – |
2016-07-15 |
4 |
S |
$7.01 |
$7,592 |
D/D |
(1,083) |
103,320 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
• – – |
2016-10-05 |
4 |
S |
$5.38 |
$3,481 |
D/D |
(647) |
102,673 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
• – – |
2016-10-17 |
4 |
S |
$4.86 |
$5,375 |
D/D |
(1,106) |
101,567 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
• – – |
2017-01-05 |
4 |
S |
$6.16 |
$4,675 |
D/D |
(759) |
100,808 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
• – – |
2017-01-17 |
4 |
S |
$6.24 |
$7,894 |
D/D |
(1,265) |
99,543 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
• – – |
2017-01-30 |
4 |
S |
$4.65 |
$32,476 |
D/D |
(6,984) |
92,559 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
• – – |
2017-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
48,750 |
141,309 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
• – – |
2017-04-05 |
4 |
S |
$5.80 |
$3,724 |
D/D |
(642) |
140,667 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
• – – |
2017-04-17 |
4 |
S |
$5.75 |
$6,268 |
D/D |
(1,090) |
139,577 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
• – – |
2017-05-01 |
4 |
S |
$5.97 |
$8,603 |
D/D |
(1,441) |
138,136 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
• – – |
2017-07-05 |
4 |
S |
$7.67 |
$4,916 |
D/D |
(641) |
137,495 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
• – – |
2017-07-31 |
4 |
S |
$7.14 |
$10,317 |
D/D |
(1,445) |
136,050 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
• – – |
2017-10-05 |
4 |
S |
$7.19 |
$4,530 |
D/D |
(630) |
135,420 |
0 |
- |
|
68 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
